Baxter to Sell Its BioPharma Solutions Business to Advent for $4.25B
The transaction is expected to close in the second half of 2023.
Source: mbtmag.com
Page 3 - Iodine Software News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Iodine Software. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Iodine Software Today - Breaking & Trending Today
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformationNet proceeds planned to be redeployed for debt repayment in accordance with Baxter’s stated capital allocation prioritiesEstablishes a diversified...
Source: pharmiweb.com
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion
DEERFIELD, Ill. & BOSTON & NEW YORK--(BUSINESS WIRE)--May 8, 2023--
Source: wsiltv.com
Baxter International : Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion
PDF - 2023-05-08 Baxter International Inc. , a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma... | May 8, 2023
Source: marketscreener.com
KLAS: Clinical Documentation Strategies 2023
A new report by KLAS examines physician-facing documentation technology and services, along with how vendors compare in overall scores, and the key performanice…
Source: hitconsultant.net